Guardian Pharmacy Services will restrict transfers of approximately 29.9 million Class A shares through September 14, 2027, under agreements with founders, executives and certain employees. The restrictions cover approximately 81% of the approximately 37 million shares held by those pre-IPO holders after the September 27 conversion.
Key Highlights
- Guardian Pharmacy Services will issue 13,521,396 Class A shares on September 27 through an automatic Class B conversion.
- The locked-up shares represent approximately 81% of approximately 37 million Class A shares held by relevant pre-IPO holders.
- Class A shares outstanding will reach 63,320,300 after the September 27 issuance.
Guardian Pharmacy Services, Inc. (NYSE: GRDN) has agreed with founders, executive officers and certain employees to restrict transfers of approximately 29.9 million Class A common shares through September 14, 2027. The restrictions became effective September 10, 2026. Subject to limited exceptions and the company’s prior consent, the covered holders cannot offer, sell, distribute, dispose of or transfer the approximately 29.9 million Class A shares during the lock-up period. The agreements apply to founders, executive officers and certain other employees. Those holders are collectively subject to the restrictions after giving effect to the planned issuance connected with the final Tranche of Class B common stock issued during Guardian Pharmacy Services’ reorganization in September 2024.
September 27 Conversion Sets Share Count
The automatic conversion will issue 13,521,396 Class A common shares on September 27, 2026. Guardian Pharmacy Services said the locked-up shares will account for approximately 81% of the approximately 37 million Class A shares held by founders, executive officers and other employees who owned common stock before the initial public offering. The company expects to have 63,320,300 Class A common shares outstanding after the conversion and issuance. The lock-up agreements remain in effect through September 14, 2027, subject to the stated exceptions and consent provision.
FAQs
Q: What shares are covered by the Guardian Pharmacy Services lock-up agreement?
A: The agreement covers approximately 29.9 million Class A common shares held by founders, executive officers and certain employees. Transfers require company consent, subject to limited exceptions.
Q: When will Guardian Pharmacy Services issue new Class A shares?
A: Guardian Pharmacy Services will issue 13,521,396 Class A common shares on September 27, 2026. The issuance follows automatic conversion of the final Class B tranche.
Q: What does the GRDN share lock-up mean for investors?
A: The GRDN lock-up restricts transfers of approximately 29.9 million Class A shares through September 14, 2027. Those shares represent approximately 81% of the relevant holders’ approximately 37 million shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.